Miracor Medical Systems GmbH-医療機器分野:企業M&A・提携分析

◆英語タイトル:Miracor Medical Systems GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010995
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and impulse catheter, which are based on proprietary platform PICSO technology. Miracor Medical’s technology is used for treatment of acute ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. The company also conducts post market clinical trials on PICSO impulse system in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention. Miracor Medical is headquartered in Vienna, Austria.

Miracor Medical Systems GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miracor Medical Systems GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Miracor Medical Systems GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Miracor Medical Systems GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Miracor Medical Systems GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Miracor Medical Systems GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Miracor Medical Systems GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Miracor Medical Systems Raises Additional USD7.6 Million in Series C Financing 10
Miracor Medical Systems Raises USD5.3 Million in Extended Series B Venture Financing 11
Miracor Medical Systems Secures US$10 Million In First Tranche Of Series B Financing Round 13
Miracor Medical Systems GmbH – Key Competitors 15
Miracor Medical Systems GmbH – Key Employees 16
Miracor Medical Systems GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Miracor Medical Systems GmbH, Medical Equipment, Key Facts 2
Miracor Medical Systems GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Miracor Medical Systems GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Miracor Medical Systems GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Miracor Medical Systems GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Miracor Medical Systems GmbH, Deals By Market, 2011 to YTD 2017 8
Miracor Medical Systems GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Miracor Medical Systems Raises Additional USD7.6 Million in Series C Financing 10
Miracor Medical Systems Raises USD5.3 Million in Extended Series B Venture Financing 11
Miracor Medical Systems Secures US$10 Million In First Tranche Of Series B Financing Round 13
Miracor Medical Systems GmbH, Key Competitors 15
Miracor Medical Systems GmbH, Key Employees 16
Miracor Medical Systems GmbH, Subsidiaries 17

★海外企業調査レポート[Miracor Medical Systems GmbH-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electricity Authority of Cyprus:企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The Reject Shop Limited (TRS):企業の財務・戦略的SWOT分析
    The Reject Shop Limited (TRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Intersil Corporation (ISIL):企業の財務・戦略的SWOT分析
    Intersil Corporation (ISIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • Bourbon SA (GBB):石油・ガス:M&Aディール及び事業提携情報
    Summary Bourbon SA (Bourbon) is a provider of marine and subsea services to the oil and gas industry. The company’s services consist of transport and supply of offshore material, floating production, storage and offloading (FPSO) support, anchor handling, towage and offshore positioning, assistance, …
  • Rhenus SE & Co KG:企業のM&A・事業提携・投資動向
    Rhenus SE & Co KG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rhenus SE & Co KG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Intertech Bilgi Islem ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • IndusInd Bank Ltd:企業の戦略・SWOT・財務情報
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • University of California Berkeley-製薬・医療分野:企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • AGC Inc (5201):企業の財務・戦略的SWOT分析
    AGC Inc (5201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The co …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Oscotec Inc (039200):企業の財務・戦略的SWOT分析
    Summary Oscotec Inc (Oscotec) is a biotechnology company which discovers and develops drugs for cancer treatments. The company’s pipeline products include SKI-O-703, a spleen tyrosine kinase (SYK) inhibitor, against rheumatoid arthritis and idiopathic thrombocytopenic purpura; lazertinib (GNS-1480 Y …
  • MAXrad SOFTware (India) Pvt Ltd:企業の戦略・SWOT・財務分析
    MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Williams-Sonoma, Inc.:戦略・SWOT・企業財務分析
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆